DE69901396D1 - Zusammensetzung enthaltend beta-hydroxy-beta-methylbutyratsäuere und mindestens ein aminosäure - Google Patents
Zusammensetzung enthaltend beta-hydroxy-beta-methylbutyratsäuere und mindestens ein aminosäureInfo
- Publication number
- DE69901396D1 DE69901396D1 DE69901396T DE69901396T DE69901396D1 DE 69901396 D1 DE69901396 D1 DE 69901396D1 DE 69901396 T DE69901396 T DE 69901396T DE 69901396 T DE69901396 T DE 69901396T DE 69901396 D1 DE69901396 D1 DE 69901396D1
- Authority
- DE
- Germany
- Prior art keywords
- beta
- acid
- hydroxy
- composition containing
- methylbutyrate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Emergency Medicine (AREA)
- Neurology (AREA)
- Nutrition Science (AREA)
- AIDS & HIV (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pulmonology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/102,941 US6031000A (en) | 1998-06-23 | 1998-06-23 | Composition comprising β-hydroxy-β-methylbutyric acid and at least one amino acid and methods of use |
PCT/US1999/014097 WO1999066917A2 (en) | 1998-06-23 | 1999-06-23 | Composition comprising ss-hydroxy-ss-methylbutyric acid and at least one amino acid |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69901396D1 true DE69901396D1 (de) | 2002-06-06 |
DE69901396T2 DE69901396T2 (de) | 2002-08-29 |
Family
ID=22292520
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69901396T Expired - Lifetime DE69901396T2 (de) | 1998-06-23 | 1999-06-23 | Zusammensetzung enthaltend beta-hydroxy-beta-methylbutyratsäuere und mindestens ein aminosäure |
Country Status (12)
Country | Link |
---|---|
US (1) | US6031000A (de) |
EP (1) | EP1089726B1 (de) |
JP (2) | JP5064609B2 (de) |
AU (1) | AU756353B2 (de) |
CA (1) | CA2334761C (de) |
DE (1) | DE69901396T2 (de) |
DK (1) | DK1089726T3 (de) |
ES (1) | ES2177293T3 (de) |
NO (2) | NO329914B1 (de) |
NZ (1) | NZ508395A (de) |
PL (1) | PL195623B1 (de) |
WO (1) | WO1999066917A2 (de) |
Families Citing this family (48)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3362350B2 (ja) * | 1997-10-16 | 2003-01-07 | 味の素株式会社 | 反芻動物の肥育方法 |
US20040220266A1 (en) * | 2002-09-09 | 2004-11-04 | Wiley David B. | Composition and method for enhancing the bioavailability of calcium and magnesium in dietary supplements and food additives |
US20040106678A1 (en) * | 2002-09-17 | 2004-06-03 | Dobbins Thomas A | Compositions for the parenteral administration of calcium and magnesium |
US6812249B2 (en) * | 2003-03-04 | 2004-11-02 | Sal Abraham | Process for preparing a 3-hydroxy-3-methylbutyrate amino acid salt and method of use |
US20050215640A1 (en) * | 2004-03-26 | 2005-09-29 | Baxter Jeffrey H | HMB compositions and uses thereof |
WO2007056176A2 (en) * | 2005-11-03 | 2007-05-18 | Southwest Immunology, Inc. | Compositions for preventing and reducing delayed onset muscle soreness |
CA2631647A1 (en) * | 2005-11-30 | 2007-06-07 | Nestec S.A. | Use of branched-chain amino acids for the treatment of muscle loss |
CN102225060A (zh) | 2005-12-19 | 2011-10-26 | 雅培制药有限公司 | β-羟基-β-甲基丁酸盐在调节1-型和2-型细胞因子生成失衡中的应用 |
US8324175B2 (en) | 2006-02-16 | 2012-12-04 | Young Hee Ko | Compositions and methods for the treatment of cancer |
US7754693B2 (en) * | 2006-02-16 | 2010-07-13 | Young Hee Ko | Composition and method for the efficacious and safe administration of halopyruvate for the treatment of cancer |
PT2381784T (pt) * | 2008-12-09 | 2018-10-30 | Metabolic Tech Inc | Intervenção nutricional para melhorar função e força muscular |
US9707241B2 (en) | 2008-12-09 | 2017-07-18 | Metabolic Technologies, Inc. | Nutritional intervention for improving muscular function and strength |
US9770424B2 (en) * | 2008-12-09 | 2017-09-26 | Metabolic Technologies, Inc. | Nutritional intervention for improving muscular function and strength |
US9259430B2 (en) | 2008-12-09 | 2016-02-16 | Metabolic Technologies, Inc. | Nutritional intervention for improving muscular function and strength |
US11173167B2 (en) | 2008-12-09 | 2021-11-16 | Metabolic Technologies, Inc. | Nutritional intervention for improving muscular function and strength |
US9539224B2 (en) | 2008-12-09 | 2017-01-10 | Metabolic Technologies, Inc. | Nutritional intervention for improving muscular function and strength |
PL2391363T3 (pl) * | 2009-01-29 | 2017-03-31 | Young Hee Ko | Kompozycje i sposoby do leczenia raka |
EP2289555A1 (de) * | 2009-08-24 | 2011-03-02 | OrgaNext Research B.V. | Verfahren zur Behandlung von Gebrechlichkeit |
WO2011075741A1 (en) * | 2009-12-18 | 2011-06-23 | Metabolic Technologies, Inc. | Improved method of administering beta-hydroxy-beta-methylbutyrate (hmb) |
PE20121729A1 (es) | 2010-01-29 | 2013-01-16 | Abbott Lab | Emulsiones nutricionales que comprenden beta-hidroxi-beta-metilbutirato (hmb) de calcio |
US9693577B2 (en) | 2010-01-29 | 2017-07-04 | Abbott Laboratories | Method of preparing a nutritional powder comprising spray dried HMB |
US8916217B2 (en) | 2010-01-29 | 2014-12-23 | Abbott Laboratories | Aseptically packaged nutritional liquids comprising HMB |
TWI526161B (zh) | 2010-06-10 | 2016-03-21 | 亞培公司 | 包含鈣hmb及可溶性蛋白質之實質上透明營養液 |
WO2013012760A1 (en) | 2011-07-15 | 2013-01-24 | Numeta Sciences, Inc. | Compositions and methods for modulating metabolic pathways |
US9327001B2 (en) | 2011-11-03 | 2016-05-03 | University Of Florida Research Foundation, Inc. | Nutritional supplement for weight management |
ES2785094T3 (es) * | 2011-11-21 | 2020-10-05 | Emmaus Medical Inc | Métodos y composiciones para el tratamiento de la diabetes y los síntomas relacionados |
CA2860642C (en) | 2012-01-11 | 2016-11-01 | Abbott Laboratories | Combination of beta-hydroxy-beta-methylbutyrate, arginine and glutamine for use in treating diabetic ulcers |
US9198454B2 (en) | 2012-03-08 | 2015-12-01 | Nusirt Sciences, Inc. | Compositions, methods, and kits for regulating energy metabolism |
HUE065064T2 (hu) | 2012-09-10 | 2024-05-28 | Metabolic Tech Llc | HMB-t éa ATP-t tartalmazó készítmények és felhasználásuk |
WO2014047493A1 (en) * | 2012-09-21 | 2014-03-27 | Abbott Laboratories | Nutritional compositions including calcium beta-hydroxy-beta-methylbutyrate and protein |
MX2015003660A (es) | 2012-09-21 | 2015-06-05 | Abbott Lab | Composiciones nutricionales que incluyen beta-hidroxi-beta-metilbu tirato de calcio, proteina y bajos niveles de electrolitos. |
CN108452311A (zh) | 2012-11-13 | 2018-08-28 | 纽斯尔特科学公司 | 用于增强能量代谢的组合物和方法 |
SG11201507390SA (en) * | 2013-03-14 | 2015-10-29 | Abbott Lab | Treatment of insulin resistance associated with prolonged physical inactivity |
SG11201507046UA (en) | 2013-03-15 | 2015-10-29 | Nusirt Sciences Inc | Leucine and nicotinic acid reduces lipid levels |
US20150057350A1 (en) * | 2013-08-23 | 2015-02-26 | Abbott Laboratories | Fibrosis biomarkers and methods of using same |
MX2016011063A (es) | 2014-02-27 | 2016-11-30 | Nusirt Sciences Inc | Composiciones y metodos para la reduccion o prevencion de esteatosis hepatica. |
CN107847759A (zh) * | 2015-06-01 | 2018-03-27 | 代谢科技有限公司 | 用于减少脂肪量的β‑羟基‑β‑甲基丁酸(HMB)的组合物和使用方法 |
PT3349745T (pt) | 2015-09-16 | 2024-03-18 | Metabolic Tech Inc | Composições e métodos de utilização de beta-hidroxi-beta metilbutirato (hmb) para melhorar a recuperação de traumatismos de tecidos moles |
CN108473411B (zh) * | 2015-11-19 | 2022-08-12 | 协和发酵生化株式会社 | 3-羟基异戊酸的一价阳离子盐的晶体及该晶体的制造方法 |
CA3011981C (en) | 2016-01-21 | 2024-01-16 | Metabolic Technologies, Inc. | Compositions and methods of use of .beta.-hydroxy-.beta.-methylbutyrate (hmb) for modulating autophagy and lipophagy |
WO2017184788A1 (en) * | 2016-04-19 | 2017-10-26 | Keto Patent Group, Inc. | Administration of butyrate, beta-hydroxybutyrate, and related compounds in humans |
US11026929B2 (en) | 2016-04-19 | 2021-06-08 | Keto Patent Group, Inc. | Administration of berberine metabolites |
AU2017282515A1 (en) | 2016-06-24 | 2019-01-17 | Otsuka Pharmaceutical Factory, Inc. | Crystal of β-hydroxy β-methylbutyric acid amino acid salt and production method therefor |
JP2019531748A (ja) | 2016-10-21 | 2019-11-07 | メタボリック・テクノロジーズ,インコーポレーテッド | β−ヒドロキシ−β−メチルブチレート(HMB)およびプロバイオティックを使用する組成物および方法 |
JOP20190146A1 (ar) * | 2016-12-19 | 2019-06-18 | Axcella Health Inc | تركيبات حمض أميني وطرق لمعالجة أمراض الكبد |
CN111295187A (zh) | 2017-08-14 | 2020-06-16 | 胺细拉健康公司 | 用于治疗肝脏疾病的氨基酸组合物 |
BR112020013700A2 (pt) * | 2018-01-05 | 2020-12-01 | Texas Tech University Office of Research Commercialization | métodos para promover perda de gordura, para acelerar perda de gordura, para melhorar performance muscular e para aumentar massa livre de gordura em um indivíduo |
CN112839643A (zh) | 2018-06-20 | 2021-05-25 | 胺细拉健康公司 | 用于治疗肌肉中脂肪浸润的组合物及方法 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5157022A (en) * | 1989-11-22 | 1992-10-20 | Adrian Barbul | Method for reducing blood cholesterol using arginine |
US5028440A (en) * | 1990-01-30 | 1991-07-02 | Iowa State University Research Foundation, Inc. | Method of raising meat producing animals to increase lean tissue development |
US4992470A (en) * | 1990-02-08 | 1991-02-12 | Iowa State University Research Foundation, Inc. | Method of enhancing immune response of mammals |
BR9307035A (pt) * | 1992-09-16 | 1999-06-29 | Univ Iowa State Res Found Inc | Processo para redução dos níveis sanguíneos de colesterol total e de colesterol de lipoproteína de baixa densidade |
US5348979A (en) * | 1992-12-23 | 1994-09-20 | Iowa State University Research Foundation Inc. | Method of promoting nitrogen retention in humans |
WO1994017678A1 (en) * | 1993-02-11 | 1994-08-18 | Iowa State University Research Foundation, Inc. | Method of enhancing nutritional value of colostrum and first milk of pregnant mammals |
US5726146A (en) * | 1994-12-06 | 1998-03-10 | Natural Supplement Association, Incorporated | Non-steroidal, anabolic dietary supplement and method to increase lean mass without linked increase fat mass |
US5756469A (en) * | 1996-07-26 | 1998-05-26 | Beale; Paxton K. | Composition of pyruvate and anti-cortisol compounds and method for increasing protein concentration in a mammal |
DE29707308U1 (de) * | 1997-04-23 | 1997-06-26 | Kunz, Armin, 66450 Bexbach | Präparat zur Muskelerhaltung bzw. zur Förderung des Muskelaufbaus |
-
1998
- 1998-06-23 US US09/102,941 patent/US6031000A/en not_active Expired - Lifetime
-
1999
- 1999-06-23 WO PCT/US1999/014097 patent/WO1999066917A2/en active IP Right Grant
- 1999-06-23 DE DE69901396T patent/DE69901396T2/de not_active Expired - Lifetime
- 1999-06-23 DK DK99930567T patent/DK1089726T3/da active
- 1999-06-23 CA CA002334761A patent/CA2334761C/en not_active Expired - Lifetime
- 1999-06-23 NZ NZ508395A patent/NZ508395A/en not_active IP Right Cessation
- 1999-06-23 AU AU47080/99A patent/AU756353B2/en not_active Expired
- 1999-06-23 JP JP2000555603A patent/JP5064609B2/ja not_active Expired - Lifetime
- 1999-06-23 ES ES99930567T patent/ES2177293T3/es not_active Expired - Lifetime
- 1999-06-23 PL PL99344589A patent/PL195623B1/pl unknown
- 1999-06-23 EP EP99930567A patent/EP1089726B1/de not_active Expired - Lifetime
-
2000
- 2000-12-22 NO NO20006633A patent/NO329914B1/no not_active IP Right Cessation
-
2010
- 2010-10-18 NO NO20101440A patent/NO332374B1/no not_active IP Right Cessation
-
2011
- 2011-12-26 JP JP2011282771A patent/JP5690261B2/ja not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
AU4708099A (en) | 2000-01-10 |
WO1999066917A3 (en) | 2000-04-20 |
WO1999066917A2 (en) | 1999-12-29 |
CA2334761C (en) | 2009-04-28 |
NZ508395A (en) | 2003-09-26 |
JP2012102118A (ja) | 2012-05-31 |
DK1089726T3 (da) | 2002-07-22 |
NO329914B1 (no) | 2011-01-24 |
AU756353B2 (en) | 2003-01-09 |
CA2334761A1 (en) | 1999-12-29 |
PL344589A1 (en) | 2001-11-05 |
JP2002518440A (ja) | 2002-06-25 |
JP5064609B2 (ja) | 2012-10-31 |
EP1089726B1 (de) | 2002-05-02 |
DE69901396T2 (de) | 2002-08-29 |
US6031000A (en) | 2000-02-29 |
PL195623B1 (pl) | 2007-10-31 |
JP5690261B2 (ja) | 2015-03-25 |
NO332374B1 (no) | 2012-09-10 |
NO20006633L (no) | 2001-02-20 |
NO20101440L (no) | 2001-02-20 |
EP1089726A2 (de) | 2001-04-11 |
NO20006633D0 (no) | 2000-12-22 |
ES2177293T3 (es) | 2002-12-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69901396D1 (de) | Zusammensetzung enthaltend beta-hydroxy-beta-methylbutyratsäuere und mindestens ein aminosäure | |
DE69918233D1 (de) | Polymilchsäure zusammensetzung und daraus hergestellter film | |
DE69520644D1 (de) | Fluoreszierende Markierungszusammensetzung und erhaltene Markierung | |
ID26186A (id) | Komposisi sampo | |
ID28694A (id) | Komposisi sampo | |
ATE251130T1 (de) | Neue 3-aryl-propionsäurederivate und analoge | |
ID26926A (id) | Komposisi shampo pembentuk mode | |
DE69829086D1 (de) | Phiole für Implantat | |
ID29430A (id) | Komposisi herbisida | |
DE69915066D1 (de) | Biozide zusammensetzung und deren verwendung | |
DE69905371D1 (de) | Härtbare zusammensetzung | |
DE69830372D1 (de) | Gaserzeugende zusammensetzung und formmasse davon | |
ID27667A (id) | Komposisi coklat dan pemakaiannya | |
DE69709093D1 (de) | Verdickte saure zusammensetzung | |
ATE241597T1 (de) | Geruchsmaskierte dimethylsulfid-zusammensetzung | |
ID25508A (id) | Komposisi dematologis | |
BG105437A (en) | REFLECTIVELY MODIFIED COMPOSITIONS AND METHODS FOR OBTAINING THEM | |
DE59906436D1 (de) | Sulfid- und oxisulfidpigmente | |
DE69942892D1 (de) | Gaserzeugende zusammensetzung | |
DE69928862D1 (de) | Zusammensetzung | |
DE69920152D1 (de) | Korrosionbeständiges Mischoxidmaterial | |
DE69909465T2 (de) | Bakterizidzusammensetzung für acker- und gartenbau | |
PT878467E (pt) | Acidos 6-aminotetra-hidroisoquinolinacarboxilicos e 7-aminotetra-hidroisoquinolinacarboxilicos substituidos | |
DK1124797T3 (da) | N-Arylsulfonyl-aminosyre-omega-amider | |
DE69711907D1 (de) | Mindestens eine nukleinsäure enthaltende zusammensetzungen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |